[HTML][HTML] Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a …
SH Jafri, R Shi, G Mills - BMC cancer, 2013 - Springer
Background Systemic inflammation has been linked with cancer development, cancer
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective …
SH Jafri, R Shi, G Mills - BMC Cancer, 2013 - go.gale.com
Background Lung cancer is one of the most commonly diagnosed cancers in the United
States. It is estimated that 226,160 new cases of lung cancer will be diagnosed and 160,340 …
States. It is estimated that 226,160 new cases of lung cancer will be diagnosed and 160,340 …
[PDF][PDF] Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a …
SH Jafri, R Shi, G Mills - 2013 - scienceopen.com
Background: Systemic inflammation has been linked with cancer development, cancer
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
[引用][C] Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a …
SH Jafri, R Shi, G Mills - BMC Cancer, 2013 - cir.nii.ac.jp
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients
with metastatic non-small cell lung cancer (NSCLC): a retrospective review | CiNii Research …
with metastatic non-small cell lung cancer (NSCLC): a retrospective review | CiNii Research …
[PDF][PDF] Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a …
SH Jafri, R Shi, G Mills - 2013 - researchgate.net
Background: Systemic inflammation has been linked with cancer development, cancer
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
[HTML][HTML] Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a …
SH Jafri, R Shi, G Mills - BMC Cancer, 2013 - bmccancer.biomedcentral.com
Systemic inflammation has been linked with cancer development, cancer cachexia and poor
outcome. Advanced lung cancer inflammation index (ALI) was developed to assess degree …
outcome. Advanced lung cancer inflammation index (ALI) was developed to assess degree …
[HTML][HTML] Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a …
SH Jafri, R Shi, G Mills - BMC Cancer, 2013 - ncbi.nlm.nih.gov
Background Systemic inflammation has been linked with cancer development, cancer
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
[PDF][PDF] Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a …
SH Jafri, R Shi, G Mills - 2013 - cyberleninka.org
Background: Systemic inflammation has been linked with cancer development, cancer
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective …
SH Jafri, R Shi, G Mills - BMC cancer, 2013 - pubmed.ncbi.nlm.nih.gov
Background Systemic inflammation has been linked with cancer development, cancer
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed …
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective …
SH Jafri, R Shi, G Mills - BMC Cancer, 2013 - search.proquest.com
Systemic inflammation has been linked with cancer development, cancer cachexia and poor
outcome. Advanced lung cancer inflammation index (ALI) was developed to assess degree …
outcome. Advanced lung cancer inflammation index (ALI) was developed to assess degree …